By Ed Susman, Contributing Writer, MedPage TodayCognitive impairments associated with breast cancer treatment are not limited only to "chemobrain," but may occur with radiation or hormonal therapies as well, a researcher said here.
About 14% of individuals who had undergone therapy for a variety of cancer diagnoses complained of post-therapy memory loss compared with 8% of individuals who had not received cancer treatments (P=0.001),
"Chemobrain is sort of a misnomer, because we observed this memory-loss phenomenon among people who have undergone chemotherapy, radiation therapy or hormonal therapy for treatment of various types of cancer," Jean-Pierre told MedPage Today during a poster session here at the American Association for Cancer Research Conference on the Science of Cancer Health Disparities.
Full Article
No comments:
Post a Comment